Navidea Biopharmaceuticals to Present at Biotech Showcase 2016
January 04 2016 - 07:30AM
Business Wire
Navidea Biopharmaceuticals, Inc. (NYSE MKT: NAVB) announced that
Rick Gonzalez, President and Chief Executive Officer, will present
at the Biotech Showcase 2016, taking place in San Francisco, CA, on
Tuesday, January 12th at 2:30 PM PT (5:30 PM ET) at the Parc 55 San
Francisco – Union Square.
A live webcast of Mr. Gonzalez’s Biotech Showcase presentation
can be accessed at the following URL:
http://edge.media-server.com/m/p/6j593adk. An archived version of
the webcast will be available two hours following the presentation
and can be accessed within the Investors' section of the
Navidea website at www.navidea.com.
About Navidea
Navidea Biopharmaceuticals, Inc. (NYSE MKT: NAVB) is a
biopharmaceutical company focused on the development and
commercialization of precision immunodiagnostic agents and
immunotherapeutics. Navidea is developing multiple
precision-targeted products and platforms including Manocept™ and
NAV4694 to help identify the sites and pathways of undetected
disease and enable better diagnostic accuracy, clinical
decision-making, targeted treatment and, ultimately, patient care.
Lymphoseek® (technetium Tc 99m tilmanocept) injection, Navidea’s
first commercial product from the Manocept platform, was approved
by the FDA in March 2013 and in Europe in November 2014. Navidea’s
strategy is to deliver superior growth and shareholder return by
bringing to market novel products and advancing the Company’s
pipeline through global partnering and commercialization efforts.
For more information, please visit www.navidea.com.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20160104005760/en/
Navidea BiopharmaceuticalsInvestorsTom Baker,
617-532-0624tbaker@navidea.comorMediaSharon Correia, 978-655-2686Associate
Director, Corporate CommunicationsorDavid Shull or Chris Hippolyte,
858-717-2310david.schull@russopartnersllc.comChris.hippolyte@russopartnersllc.com
Navidea Biopharmaceuticals (AMEX:NAVB)
Historical Stock Chart
From Feb 2024 to Mar 2024
Navidea Biopharmaceuticals (AMEX:NAVB)
Historical Stock Chart
From Mar 2023 to Mar 2024